Login / Signup
Chemoproteomic Covalent Ligand Discovery as the PROTAC-gonist: The Future of Targeted Degradation Medicines.
Kyosuke Shishikura
Megan L Matthews
Published in:
ACS central science (2024)
Keyphrases
</>
small molecule
current status
cancer therapy
high throughput